US › Healthcare

Eton Pharmaceuticals Inc (ETON)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$45.83+1.53%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$24.3M
Revenue YoY
+40.4%
Net profit
$1.6M
Profit YoY
+198.9%
EPS
$0.14
EPS estimate
$0.14
Net margin
6.4%

EPS came in at 0.14 against a street estimate of 0.14 — a beat of 0.0%.

Key statistics

Market cap
$1.27B
Forward P/E
52.6
P/B
41.52
Book value
$1.12
EPS (TTM)
$-0.06
52-week high
$50.18
52-week low
$13.98
50-day MA
$35.97
200-day MA
$23.65
Beta
0.86

Analyst view

Analysts rate Eton Pharmaceuticals Inc a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $54.75.

Shareholding

Insiders
5.32%
Institutions
65.55%

Largest institutional holders

FundStake
Opaleye Management Inc10.44%
EcoR1 Capital, LLC7.93%
BlackRock Inc6.27%
Vanguard Group Inc4.92%
Nantahala Capital Management, LLC4.29%
Vanguard Capital Management, LLC3.63%
Geode Capital Management, LLC2.11%
State Street Corp1.94%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Eton Pharmaceuticals Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.